Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Rectal Spacers Use in Prostate Cancer Radiation Therapy

NCT: NCT06594887 · ACTIVE_NOT_RECRUITING

NCT IDNCT06594887
StatusACTIVE_NOT_RECRUITING
Start Date2024-09-06
Completion2027-06
SponsorPrinceton ProCure management, LLC. (OTHER)
First posted
Last updated

Brief Summary

This prospective, 2-arm clinical trial aims to evaluate the use of rectal spacers in patients with localized prostate cancer scheduled for Proton Beam Therapy (PBT). Up to 50 subjects will be enrolled in this study. Study visits will include screening, spacer placement, treatment planning, end-of-treatment assessment, and follow-up visits at 1, 3, and 6 months.

Frequently Asked Questions

What is Rectal Spacers Use in Prostate Cancer Radiation Therapy?

Rectal Spacers Use in Prostate Cancer Radiation Therapy is a clinical trial registered under NCT06594887. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT06594887?

The current status of NCT06594887 (Rectal Spacers Use in Prostate Cancer Radiation Therapy) is: ACTIVE_NOT_RECRUITING.

When did Rectal Spacers Use in Prostate Cancer Radiation Therapy start?

Rectal Spacers Use in Prostate Cancer Radiation Therapy started on 2024-09-06.

Related Devices

K172848MEVION S250i Proton Beam Radiation Therapy DeviceMevion Medical Systems K250986S250-FIT Proton Beam Radiation Therapy Device (S250-FIT)Mevion Medical Systems, Inc. K253406S250-FIT Proton Beam Radiation Therapy Device (S250-FIT)Mevion Medical Systems, Inc. K221448ARIA Radiation Therapy Management (v15.8), Eclipse Treatment Planning System (v15.8)Varian Medical Systems, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑